Tenecteplase for Acute Non–Large Vessel Occlusion Ischemic Stroke

Key Points

• Tenecteplase improves outcomes in patients with acute ischemic stroke caused by non-large vessel occlusions.
• Key evidence shows that treatment was administered between 4.5 and 24 hours after symptom onset.
• Observational analysis confirmed the presence of salvageable brain tissue in the patients treated.
• Highlights the need for timely intervention to enhance recovery potential in specific stroke types.